No connection

Search Results

KMDA vs MCTA

KMDA
Kamada Ltd.
NEUTRAL
Price
$8.49
Market Cap
$490.9M
Sector
Healthcare
AI Confidence
80%
MCTA
Charming Medical Limited
BEARISH
Price
$29.36
Market Cap
$504.3M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
KMDA
24.26
MCTA
419.36
Forward P/E
KMDA
14.31
MCTA
--
P/B Ratio
KMDA
1.82
MCTA
9785.0
P/S Ratio
KMDA
2.72
MCTA
92.98
EV/EBITDA
KMDA
10.78
MCTA
388.4

Profitability

Gross Margin
KMDA
42.34%
MCTA
96.02%
Operating Margin
KMDA
7.95%
MCTA
-0.94%
Profit Margin
KMDA
11.19%
MCTA
12.12%
ROE
KMDA
7.64%
MCTA
--
ROA
KMDA
4.37%
MCTA
10.63%

Growth

Revenue Growth
KMDA
14.5%
MCTA
-27.0%
Earnings Growth
KMDA
-14.1%
MCTA
--

Financial Health

Debt/Equity
KMDA
0.04
MCTA
1.6
Current Ratio
KMDA
4.07
MCTA
0.59
Quick Ratio
KMDA
2.2
MCTA
0.57

Dividends

Dividend Yield
KMDA
2.94%
MCTA
--
Payout Ratio
KMDA
0.0%
MCTA
0.0%

AI Verdict

KMDA NEUTRAL

KMDA presents a dichotomy between a fortress-like balance sheet and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health and the Debt/Equity ratio (0.04) is exceptionally low, the stock trades at a significant premium to its Graham Number ($6.06) and Intrinsic Value ($2.45). The attractive PEG ratio (0.63) suggests growth is undervalued, but this is offset by negative YoY earnings growth (-14.10%) and a bearish technical trend.

Strengths
Exceptional liquidity with a Current Ratio of 4.07
Negligible leverage with Debt/Equity at 0.04
Strong PEG ratio (0.63) indicating potential growth undervaluation
Risks
Significant disconnect between current price ($8.49) and Intrinsic Value ($2.45)
Negative earnings growth (-14.10% YoY) despite revenue gains
Bearish technical trend (0/100 score)
MCTA BEARISH

MCTA exhibits a severe disconnect between its market price and fundamental value, with a Piotroski F-Score of 6/9 indicating stable internal health but failing to justify a valuation that dwarfs its Graham Number ($0.07) and Intrinsic Value ($0.49). The company is trading at an astronomical Price-to-Book ratio of 9785.00 and a P/E of 419.36 despite a significant revenue contraction of 27% YoY. While gross margins are exceptionally high, negative operating margins and a current ratio of 0.59 signal poor operational efficiency and liquidity risks. The technical trend is heavily bearish, suggesting a speculative bubble that is currently deflating.

Strengths
Stable Piotroski F-Score (6/9)
Exceptionally high gross margins (96.02%)
Positive net profit margin (12.12%)
Risks
Extreme overvaluation (Price vs. Intrinsic Value)
Significant revenue decline (-27% YoY)
Severe liquidity risk (Current Ratio 0.59)

Compare Another Pair

KMDA vs MCTA: Head-to-Head Comparison

This page compares Kamada Ltd. (KMDA) and Charming Medical Limited (MCTA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile